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Available online 31 March 2011Currentbias is CFA lesions shouldbe treatedwithopen surgery,
based on excellent results, minimal complications, concern
over stent fracture and limitation of future CFA access from
stents. DrGoueffic challenges the “lowrate”of complications,
citing 18%minor, 3.6%major by Cardon1 (2001), and 5%major/
9% minor from Kang,2 suggesting these numbers may be low.
However, more current series show 0% major/6.6% minor
complication rates for CFA endarterectomy.3
Dr Goueffic presents CFA stenting in 40 limbs, 90.7% ASA
class 3 or lower, 30% CLI without major tissue loss, with no
comparative arm. Primary outcomes were subjective rather
than objective. A variety of levels of disease, 20% EIA disease
extending to CFA, and 12.5% stenoses of prior graft anasto-
moses, as well as both self expanding and balloon expandable
stents were included. In addition, 1 patient underwent
concomitant open bypass, while 60% had multilevel endovas-
cular work. They report a peri-procedure major complication
rate of 5%, including 1 amputation. Primary sustained clinical
improvement was 80% and secondary 90% at 1 year, with 85%
freedom fromTLR. He concludes that endovascular treatment
of the CFA is feasible and safe. However, 20% of those with in-
stent restenosis at 1 year required additional interventions,
including 1 with stent fracture. Two required bypass within 6
monthswith alteration of theproximal anastomosis to thePFA.
Baumann4 evaluated endovascular CFA intervention and
found primary sustained clinical improvement rates of 55%
at 3 months dropping to 40% by 12 and 0% by 24 months, andDOI of original article: 10.1016/j.ejvs.2011.02.025.
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doi:10.1016/j.ejvs.2011.03.00281%, 68%, and 52% in claudicants. They concluded that
endovascular intervention resulted in “high” rates of sus-
tained clinical success in claudicants, while CLI was associ-
ated with poorer outcomes.
In contrast, Kang2 in 2008 found a 98.5% improvement in
symptoms with CFA endarterectomy, with 93% PP at 1 year
and 91% at 5 years. Ballotta3 reported a 7 year PP of 96%
with APP and LS rates of 100% in a population with 40% CLI.
While Dr Goueffic has demonstrated that CFA endovas-
cular interventions can be safely performed, this data does
not support widespread use in patients other than
extremely high risk, until improved long-term outcomes can
be achieved. The planned prospective study in France will
hopefully further define the use of stenting in the CFA.References
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